-
公开(公告)号：AU2013354113B2
公开(公告)日：2018-03-08
申请号：AU2013354113
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: C07D213/81 , A61K31/444 , A61P29/00 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
Abstract: The invention relates to a compound of formula (I) wherein R
-
公开(公告)号：DK2928867T3
公开(公告)日：2017-10-23
申请号：DK13799543
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: C07D213/81 , A61K31/444 , A61P29/00 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
-
公开(公告)号：ZA201503600B
公开(公告)日：2016-01-27
申请号：ZA201503600
申请日：2015-05-21
Applicant: HOFFMANN LA ROCHE
Inventor： ROEVER STEPHAN , NETTEKOVEN MATTHIAS , GRETHER UWE , ROMBACH DIDIER , RICKLIN FABIENNE , WESTPHAL MATTHIAS , SCHULZ-GASCH TANJA , ROGERS-EVANS MARK , KIMBARA ATSUSHI
Abstract: The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 agonist and can be used as an active ingredient in a medicament.
-
公开(公告)号：PH12015501082B1
公开(公告)日：2015-08-03
申请号：PH12015501082
申请日：2015-05-15
Applicant: F HOFFMANN - LA ROCHE AG
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: A61K31/444 , A61P29/00 , C07D213/81 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
Abstract: The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 agonist and can be used as an active ingredient in a medicament.
-
公开(公告)号：CA2890353A1
公开(公告)日：2014-06-12
申请号：CA2890353
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: C07D213/81 , A61K31/444 , A61P29/00 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
Abstract: The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 agonist and can be used as an active ingredient in a medicament.
-
Patent Agency Ranking16.发明专利
公开(公告)号：SG11201809678VA
公开(公告)日：2018-11-29
申请号：SG11201809678V
申请日：2017-06-20
Applicant: HOFFMANN LA ROCHE
Inventor： GOBBI LUCA , GRETHER UWE , GUBA WOLFGANG , KRETZ JULIAN , MARTIN RAINER E , WESTPHAL MATTHIAS , IJZERMAN ADRIAAN PIETER
IPC: C07D487/04 , A61K31/519 , A61P11/00 , A61P25/00 , A61P29/00 , A61P33/00 , A61P35/00
Abstract: wherein R1 to R4 and n are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
-
公开(公告)号：RS56424B1
公开(公告)日：2018-01-31
申请号：RSP20171008
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: C07D213/81 , A61K31/444 , A61P29/00 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
-
公开(公告)号：PL2928867T3
公开(公告)日：2017-12-29
申请号：PL13799543
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: C07D213/81 , A61K31/444 , A61P29/00 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
-
公开(公告)号：ES2643056T3
公开(公告)日：2017-11-21
申请号：ES13799543
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , RICKLIN FABIENNE , ROEVER STEPHAN , ROGERS-EVANS MARK , ROMBACH DIDIER , SCHULZ-GASCH TANJA , WESTPHAL MATTHIAS
IPC: C07D213/81 , A61K31/444 , A61P29/00 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
-
公开(公告)号：MA38238A1
公开(公告)日：2017-02-28
申请号：MA38238
申请日：2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor： GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHULZ-GASCH TANJA , RICKLIN FABIENNE , ROMBACH DIDIER , WESTPHAL MATTHIAS
IPC: A61K31/444 , A61P29/00 , C07D213/81 , C07D401/06 , C07D401/12 , C07D405/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D491/10
Abstract: La présente invention concerne un composé de formule (i) où r1 à r4 sont tels que définis dans la description et les revendications. Le composé de formule (i) est un agoniste de cb2 et peut être utilisé comme principe actif dans un médicament.
-
-
-
-
-
-
-
-
-
Search Results
28
records
(took 0.023 seconds)
